2.,LIF,inhibi6on,from,E6@8,altered,trophoblast,giant,cell, morphology,in,the,mouse,placenta,at,E10.,E10,implanta>on,sites,treated,with,PEG, control,or,PEGLA,from,E6F8,were,stained,with,haematoxylinFeosin,(H&E).,Abnormal, trophoblast,giant,cell,morphology,is,highlighted,(Arrows).,Bars,represent,50μm., area, in, E10, , 13, or, 17, implanta>on, sites, treated, with, PEG, control, or, PEGLA, from, E8F10, , E10F13, or, E10F17., (b) ,Staining,intensity,was,quan>fied,as,pixel,intensity/area,(%).,Data, are,mean,±,SEM., Figure,4 .,IL6,family,gene,expression,levels,were,unchanged,in,PEG,or, PEGLA,treated,mouse,placenta,from,E10@13,,at,E13.,LIF,,LIFR,,gp130,,IL11,and,IL6, mRNA,expression,were,determined,by,semiFquan>ta>ve,PCR,and,normalised,to,β2F microglobulin,(n=4/group).,Data,are,mean,±,SEM., Supplementary, Table, 1.,Effects,of,PEGLA,and,PEG,control,treatment,from,E10@E13,on, mouse,placental,gene,expression,at,E13.,Gene,expression,represented,as,genes,upF regulated, (+), , or, downregulated, (F), by, PEGLA, versus, control, from, highest, to, lowest, abundance, fold, change, from, β2Fmicroglobulin, (n=4/group) .,, ,
Gene

Primer
Sequence: forward (F) and reverse (R) Efficiency
F 5'-TTCCCGTGATCTTCTCTCTGCT-3' 92 R 5'-TCTGCTTGGCAGAAATTCCA-3' IL11 F 5'-GTTTACAGCTCTTGATGTCTC-3' 94 R 5'-GAGTCTTTAACAACAGCAGG-3' IL6 F 5'-TAGTCCTTCCTACCCCAATTT-3' 95 R 5'-TTGGTCCTTAGCCACTCCTTC-3' β2-microglobulin F 5'-GGTCTTTCTGGTGCTTGTCTCA-3' 97 R 5'-GTTCGGCTTCCCATTCTCC-3' Supplementary, Table, 2.,Primers,used,for,gene,transcrip6on,analysis.,, ,
